Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 sept. 2022 08h02 HE | Source: Novome Biotechnologies, Inc.

Novome Biotechnologies Raises $43.5 Million Series B Financing to Advance its Pipeline of Therapeutically Engineered Microbes

- Funding supports ongoing Phase 2a clinical trial in patients with enteric hyperoxaluria, and pipeline of GEMMs candidates for inflammatory bowel disease - - Financing includes new investors led by...
17 nov. 2021 09h02 HE | Source: Novome Biotechnologies, Inc.

Novome Biotechnologies Reports Positive Results from a Phase 1 Study of NOV-001

- Orally-administered Genetically Engineered Microbial Medicine (GEMM) was safe and well tolerated and demonstrated dose-dependent strain engraftment in healthy volunteers - - Results provide...
22 juin 2021 08h00 HE | Source: Novome Biotechnologies, Inc.

Novome Biotechnologies Appoints Dr. Lachy McLean as Chief Medical Officer

SOUTH SAN FRANCISCO, Calif., June 22, 2021 (GLOBE NEWSWIRE) -- Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living medicines for chronic diseases, today...